Pfizer Inc banner

Pfizer Inc
XHAM:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
XHAM:PFE
Watchlist
Price: 22.785 EUR 0.68%
Market Cap: €129.5B

Relative Value

The Relative Value of one PFE stock under the Base Case scenario is hidden EUR. Compared to the current market price of 22.785 EUR, Pfizer Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFE Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

PFE Competitors Multiples
Pfizer Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Pfizer Inc
XHAM:PFE
150.3B EUR 2.4 19.4 7.3 9.7
US
Eli Lilly and Co
NYSE:LLY
965.4B USD 14.7 46.3 31.2 33.2
US
Johnson & Johnson
NYSE:JNJ
592B USD 6.2 21.7 15.1 18.5
CH
Roche Holding AG
SIX:ROG
291.7B CHF 4.8 31.1 13.1 15.3
UK
AstraZeneca PLC
LSE:AZN
237.7B GBP 5.5 31.7 17.5 24.6
CH
Novartis AG
SIX:NOVN
242.2B CHF 5.5 22.2 13.7 17.6
US
Merck & Co Inc
NYSE:MRK
301.7B USD 4.7 16.6 10.3 12.1
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.3 13 9.5 11.2
UK
GlaxoSmithKline PLC
LSE:GSK
90.6B GBP 2.8 15.8 7.9 11.3
UK
GSK plc
XETRA:GS71
103.6B EUR 2.8 15.8 8 11.3
P/E Multiple
Earnings Growth PEG
US
Pfizer Inc
XHAM:PFE
Average P/E: 23.3
19.4
26%
0.7
US
Eli Lilly and Co
NYSE:LLY
46.3
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.7
7%
3.1
CH
Roche Holding AG
SIX:ROG
31.1
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.7
26%
1.2
CH
Novartis AG
SIX:NOVN
22.2
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.6
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13
7%
1.9
UK
GlaxoSmithKline PLC
LSE:GSK
15.8
18%
0.9
UK
GSK plc
XETRA:GS71
15.8
18%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Pfizer Inc
XHAM:PFE
Average EV/EBITDA: 42.4
7.3
-4%
N/A
US
Eli Lilly and Co
NYSE:LLY
31.2
18%
1.7
US
Johnson & Johnson
NYSE:JNJ
15.1
2%
7.5
CH
Roche Holding AG
SIX:ROG
13.1
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.5
11%
1.6
CH
Novartis AG
SIX:NOVN
13.7
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.3
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
7%
1.4
UK
GlaxoSmithKline PLC
LSE:GSK
7.9
2%
4
UK
GSK plc
XETRA:GS71
8
2%
4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Pfizer Inc
XHAM:PFE
Average EV/EBIT: 90.9
9.7
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
33.2
17%
2
US
Johnson & Johnson
NYSE:JNJ
18.5
6%
3.1
CH
Roche Holding AG
SIX:ROG
15.3
6%
2.5
UK
AstraZeneca PLC
LSE:AZN
24.6
24%
1
CH
Novartis AG
SIX:NOVN
17.6
12%
1.5
US
Merck & Co Inc
NYSE:MRK
12.1
6%
2
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
8%
1.4
UK
GlaxoSmithKline PLC
LSE:GSK
11.3
12%
0.9
UK
GSK plc
XETRA:GS71
11.3
12%
0.9